Please assess the completion status of the following clinical trial:

Trial Title: An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female outpatients who are at least 6 years of age and who will not have reached their 12th birthday~* Diagnosis of ADHD~* Normal intelligence~Exclusion Criteria:~* Weigh less than 20 kg or more than 60 kg at study entry~* Other relevant psychiatric diagnoses~* Are at serious suicidal risk as determined by the investigator~* Have a history of severe allergies~* Alcohol or drug abuse within the past 3 months

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).